Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LAMTOR1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | LAMTOR1 |
| Full Name | Late Endosomal/Lysosomal Adaptor 1 |
| Aliases | Page for LAMTOR1 |
| Function | LAMTOR1 (Late Endosomal/Lysosomal Adaptor 1) is a key component of the ragulator complex that regulates mTORC1 signaling. |
| Pathways | MTOR, mTOR, MAPK, mtor |
| Ensembl ID | ENSG00000149357 |
| GeneCards | LAMTOR1 |
| Human Protein Atlas | LAMTOR1 |
| mTORC1 Activation | LAMTOR1 is essential for mTORC1 activation by amino acids. The ragulator complex localizes to lysosomes where it activates mTORC1 in response to nutrient availability. |
| Rag GTPase Regulation | LAMTOR1 forms a complex with LAMTOR2 and LAMTOR3, acting as a guanine nucleotide exchange factor (GEF) for Rag GTPases. |
| Lysosomal Trafficking | The LAMTOR complex regulates endosomal and lysosomal trafficking, influencing autophagy and nutrient sensing. |
| ERK Pathway Modulation | LAMTOR1 also modulates ERK/MAPKmechanisms/mapk-signaling-neurodegeneration) signaling, connecting it to cell growth and differentiation. |
| Autophagy Impairment | LAMTOR1 is crucial for autophagy, and its dysfunction may lead to accumulation of amyloid and tau aggregates. |
| Lysosomal Function | The protein's role in lysosomal signaling affects cellular waste clearance, which is impaired in AD. |
| Autophagy-Lysosome Pathway | LAMTOR1 dysfunction contributes to impaired autophagy and α-synuclein clearance. |
| Associated Diseases | neurodegeneration |
| Interactions | AUTOPHAGY, MTORC1, MTOR, AND, MAPK |
| SciDEX Hypotheses | Mitochondrial-Lysosomal Coupling Enhancer |
| KG Connections | 40 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
LAMTOR1["<b>LAMTOR1</b>"]
Fibrosis{"Fibrosis"}
LAMTOR1 -->|"therapeutic target"| Fibrosis
Hepatitis{"Hepatitis"}
LAMTOR1 -->|"therapeutic target"| Hepatitis
Cancer{"Cancer"}
LAMTOR1 -->|"therapeutic target"| Cancer
Cirrhosis{"Cirrhosis"}
LAMTOR1 -->|"therapeutic target"| Cirrhosis
Inflammation{"Inflammation"}
LAMTOR1 -->|"therapeutic target"| Inflammation
Ms{"Ms"}
LAMTOR1 -->|"therapeutic target"| Ms
AMPK["AMPK"]
LAMTOR1 -->|"therapeutic target"| AMPK
MTOR["MTOR"]
LAMTOR1 -->|"therapeutic target"| MTOR
Mtor(["Mtor"])
LAMTOR1 -->|"therapeutic target"| Mtor
Autophagy(["Autophagy"])
LAMTOR1 -->|"activates"| Autophagy
Mapk(["Mapk"])
LAMTOR1 -->|"activates"| Mapk
INFLAMMATION["INFLAMMATION"]
LAMTOR1 -->|"therapeutic target"| INFLAMMATION
MTOR -->|"therapeutic target"| LAMTOR1
style LAMTOR1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cirrhosis | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Fatty Liver | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| MTOR | therapeutic_target | gene | 0.60 |
| AMPK | therapeutic_target | gene | 0.60 |
| Mtor | therapeutic_target | pathway | 0.60 |
| Autophagy | activates | pathway | 0.60 |
| Mapk | activates | pathway | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| Ampk Signaling | therapeutic_target | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| neurodegeneration | associated_with | disease | 0.50 |
| mTOR | regulates | pathway | 0.50 |
| TFE3 | co_associated_with | gene | 0.40 |
| TFEB | co_associated_with | gene | 0.40 |
| ULK1 | co_associated_with | gene | 0.40 |
| YWHAG | co_associated_with | gene | 0.40 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-e3a48208 | targets_gene | hypothesis | 0.90 |
| MTOR | therapeutic_target | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| AMPK | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| h-e3a48208 | targets | hypothesis | 0.50 |
| ATP6V1A | co_associated_with | gene | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Mitochondrial-Lysosomal Coupling Enhancer | 0.422 | neurodegeneration | Does TFEB dysfunction cause neurodegener |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.510
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| ZDHHC9 palmitoylates LAMTOR1 to promote renal cell carcinoma malignant progressi [PMID:41856969] | Liu B, Hou T, Liu X, Liu L, Ma Z et al. | Cell Death Dis | 2026 | 0 |